Phase II Study Using Thalidomide for the Treatment of ALS

Clinical trial NCT00140452 · COMPLETED

Trial details

NCT number: NCT00140452
Sponsor: Dartmouth-Hitchcock Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis ALS

Start date: 2005-02-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.